Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma

被引：0
|
作者：
Leanne Kaye
Vy Vuong
Meredith A. Barrett
Elroy Boers
Theresa Guilbert
机构：
[1] ResMed Science Center,Department of Pediatrics
[2] ResMed Science Center,undefined
[3] University of Cincinnati and Pulmonary Division,undefined
[4] Cincinnati Children’s Hospital Medical Center,undefined
来源：
npj Primary Care Respiratory Medicine | / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.
引用
收藏
相关论文
共 50 条
  • [11] PREDICTIVE ABILITY AND CLINICAL USEFULNESS OF SHORT-ACTING BETA-AGONIST USE AS A MARKER OF FUTURE ASTHMA EXACERBATIONS
    Kim, C.
    Hoch, H.
    McQueen, R. B.
    Sullivan, P. W.
    Saba, L.
    Campbell, J. D.
    [J]. VALUE IN HEALTH, 2019, 22 : S359 - S359
  • [12] Relationship between short-acting beta-agonist use and self-assessment responses in patients with asthma
    Hoyte, Flavia
    Mosnaim, Giselle
    Wechsler, Michael
    Safioti, Guilherme
    Sagalovich, Katja
    Brown, Randall
    Depietro, Michael
    Hill, Tanisha
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB158 - AB158
  • [13] Dose counting and use of short-acting beta-agonist inhalers in emergency department patients with asthma exacerbation
    Luthe, Sarah Kyuragi
    Goto, Tadahiro
    Chipps, Bradley E.
    Pallin, Daniel J.
    Stoyanov, Stanislav
    Camargo, Carlos A., Jr.
    Hasegawa, Kohei
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (02) : 256 - +
  • [14] Is Overuse of Short-Acting Beta-Agonist (SABA) Associated with Increased Mortality and Asthma Morbidity in Individuals with Asthma in Ontario, Canada?
    To, T.
    Fong, I
    Zhu, J.
    Terebessy, E.
    Zhang, K.
    Licskai, C.
    Gershon, A. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [15] THE RISK OF SHORT-ACTING BETA-AGONIST OVER-RELIANCE
    Wang, Hao-Chien
    Djajalaksana, Susanthy
    Sharma, Latha
    Theerakittikul, Theerakorn
    Lim, Hui Fang
    Yoo, Kwang Ha
    Yu-Lin, Andrea Ban
    Diaz, Dina V.
    Yang, Lala
    Beekman, Maarten J. H. I.
    [J]. RESPIROLOGY, 2021, 26 : 7 - 7
  • [16] ASTHMA CONTROL EVALUATED WITH ELECTRONIC MEDICATION MONITOR (EMM)-DEFINED OCCASIONS OF SHORT-ACTING BETA-AGONIST INHALER USE
    Anderson, W.
    Hoch, H.
    Gondalia, R.
    Kaye, L.
    Barrett, M.
    Van Sickle, D.
    Szefler, S.
    Stempel, D.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S40 - S40
  • [17] Reducing short-acting beta-agonist (SABA) use in asthma: findings from SENTINEL Plus early adopter sites
    Crooks, Michael
    Sykes, Dominic
    Cummings, Helena
    Morice, Alyn
    Brooks, Samantha
    Jackson, Arthur
    Xu, Yang
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [18] Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London
    De Simoni, Anna
    Hajmohammadi, Hajar
    Pfeffer, Paul
    Cole, Jim
    Griffiths, Chris
    Hull, Sally A.
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2022, : E619 - E626
  • [19] Real-World Patterns and Implications of Short-Acting Beta-Agonist Use Among Adolescent and Adult Patients with Asthma
    Lugogo, N.
    Gilbert, I.
    Goshi, N.
    Gandhi, H.
    Moore-Schiltz, L.
    Tkacz, J.
    Lanz, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [20] Short-Acting Beta-Agonist Bursts and Overuse in Patients with Poorly Controlled Asthma, as Recorded by a Digital Inhaler
    Castro, M.
    Safioti, G.
    DePietro, M.
    Brown, R.
    Reich, M.
    Levy, M. L.
    Kocks, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345